A review on recent advances in drugs for lung cancer treatment

A review on recent advances in drugs for lung cancer treatment

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.

Bibliografische gegevens
Hoofdauteur:	Noor, Fouzia
Andere auteurs:	Akter, Raushanara
Formaat:	Thesis
Taal:	English
Gepubliceerd in:	Brac University 2024
Onderwerpen:	Lung cancer Recent advances Drugs Resistance Mechanism of action Lung cancer > Treatment
Online toegang:	http://hdl.handle.net/10361/22049

Gelijkaardige items

Potential of liposomes for the treatment of lung cancer- a review
door: Mim, Shanzida
Gepubliceerd in: (2023)

A review on targeted therapies for lung cancer
door: Ashraf, Anushey
Gepubliceerd in: (2023)

Molecules associated with the development of lung cancer
door: Rahman, Adree, et al.
Gepubliceerd in: (2023)

Impact of treatment size and therapy type in phase II clinical trials of non-small cell lung cancer
door: Rahman, Tasnim
Gepubliceerd in: (2024)

Protein biomarkers for Lung Cancer: a bioinformatic approach
door: Jeba, Joynob
Gepubliceerd in: (2017)

Recent developments in the Adeno-Associated Viral Gene Therapy for Non-Small Cell Lung Cancer during the past 20 years
door: Razna, Amrin Islam
Gepubliceerd in: (2019)

Immunotherapy in the Management of Lung Cancer
door: Tasnim, Humayra
Gepubliceerd in: (2022)

A cross-sectional study on risk factors, symptoms, treatment and management strategies of lung cancer in a tertiary care cancer hospital of Bangladesh
door: Pial, Sazia Afrin
Gepubliceerd in: (2018)

Computational insights into molecular docking strategies for non-small cell lung cancer drug discovery
door: Das, Reshita
Gepubliceerd in: (2024)

Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
door: Tania, Umme
Gepubliceerd in: (2023)

Bioinformatics analyses of key regulators of NF-κB pathway in relation with small cell lung carcinoma
door: Zangmo, Thinley
Gepubliceerd in: (2024)

Efficacy analysis and prediction in phase II clinical trials of non-small cell Lung Cancer
door: Hoque, Ismoth Ara
Gepubliceerd in: (2024)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
door: Flora, Sanzida Alam
Gepubliceerd in: (2024)

A case study of lung cancer patients in term of various risk factors in context of Bangladesh
door: Shabnam, Musharrat
Gepubliceerd in: (2018)

Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
door: Paul, Pulock
Gepubliceerd in: (2024)

An overview of the clinical management and challenges of treatments for the patients diagnosed with COVID-19 and lung carcinoma
door: Bristy, Israt Zerin
Gepubliceerd in: (2021)

Current practice and approaches of immunotherapy in Cancer treatment
door: Khondokar, Faiza
Gepubliceerd in: (2022)

A comprehensive review on drug repurposing in cancer treatment
door: Sarkar, Onusree
Gepubliceerd in: (2024)

A review of Breast Cancer risk factor assessment on women in developing countries, cancer drug resistance, and Breast Cancer treatment in Bangladesh
door: Raihan, Dilraj
Gepubliceerd in: (2024)

Lung cancer detection and classification using machine learning
door: Arefin, Mahbubul, et al.
Gepubliceerd in: (2023)

Lung cancer immunosuppression and therapeutic targeting of myeloid- derived suppressor cells
door: Nandy, Aditi
Gepubliceerd in: (2022)

Recent advancement on breast cancer detection and treatment
door: Rahman, Sanjida
Gepubliceerd in: (2023)

Drug repurposing: potential of Antimicrobial Drugs in Breast Cancer Treatment
door: Chakraborty, Anuradha
Gepubliceerd in: (2024)

RIPK pathway, as a potential target, for cancer treatment - a review
door: Jahan, Nusrat
Gepubliceerd in: (2024)

A review on nanoparticles based drug delivery in cancer treatment: advantages & challenges
door: Nahar, Kamrun
Gepubliceerd in: (2023)

Score based risk assessment of lung cancer and its evaluation for Bangladeshi people
door: Mukti, Roushney Fatima, et al.
Gepubliceerd in: (2016)

Identification of the multi-drug resistant genes in the bacteria isolated from the saliva of smoker oral cancer patients and comparative analysis with smoker normal individuals
door: Hasan, Samir, et al.
Gepubliceerd in: (2024)

Natural products and their combinatory effects in breast cancer treatment
door: Siddique, Md. Ayman
Gepubliceerd in: (2021)

Precision medicine in four deadliest Cancers of the world : present practices & future prospects
door: Islam, Ankita
Gepubliceerd in: (2022)

A review on the recent advancements on nanoparticles drug delivery approaches in anti-cancer treatment
door: Hoque, Syeda Mehren
Gepubliceerd in: (2024)

Microneedles in pain management of Cancer
door: Islam, Shafiqul
Gepubliceerd in: (2022)

Breast cancer therapy through Liposomal drug delivery system
door: Ome, Nusrat Jahan
Gepubliceerd in: (2024)

Evaluation of genetics of cancer predisposition in patients and efficacy of various chemotherapeutic drugs in Bangladesh
door: Hossain, Safa Binte
Gepubliceerd in: (2019)

Potential phytochemicals and dietary components for the prevention and treatment of skin cancer: A review
door: Muntaha, Habibatul
Gepubliceerd in: (2023)

Pooled analysis of response rate and overall survival of Tyrosine Kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
door: Karim, Samia Binte
Gepubliceerd in: (2024)

Biosimilar in lymphoma treatment
door: Tanisha, Mehrin Haque
Gepubliceerd in: (2021)

Therapeutic prospective of targeting calcium homeostasis in cancer – a review
door: Kamal, Tasnova
Gepubliceerd in: (2019)

A review on carbon nanotube: a new era in cancer diagnosis & therapy
door: Parvez, Safi
Gepubliceerd in: (2023)

The impact of cell penetrating peptides in prospective cancer therapy: a review
door: Nashrah, Zannatul
Gepubliceerd in: (2023)

Palliative care services in cancer treatment: a study of the current scenario in Dhaka
door: Rahman, Qazi Ashrafur
Gepubliceerd in: (2018)